Trexquant Investment LP acquired a new position in AngioDynamics, Inc. (NASDAQ:ANGO) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 10,220 shares of the medical instruments supplier’s stock, valued at approximately $175,000.

Other institutional investors have also modified their holdings of the company. Vanguard Group Inc. increased its holdings in AngioDynamics by 14.4% in the 2nd quarter. Vanguard Group Inc. now owns 1,938,115 shares of the medical instruments supplier’s stock valued at $31,416,000 after buying an additional 243,825 shares during the period. Broadfin Capital LLC increased its holdings in AngioDynamics by 14.9% in the 2nd quarter. Broadfin Capital LLC now owns 1,683,252 shares of the medical instruments supplier’s stock valued at $27,286,000 after buying an additional 217,800 shares during the period. Northern Trust Corp increased its holdings in AngioDynamics by 14.9% in the 2nd quarter. Northern Trust Corp now owns 1,202,941 shares of the medical instruments supplier’s stock valued at $19,500,000 after buying an additional 155,951 shares during the period. Wells Fargo & Company MN increased its holdings in AngioDynamics by 86.3% in the 2nd quarter. Wells Fargo & Company MN now owns 1,015,594 shares of the medical instruments supplier’s stock valued at $16,463,000 after buying an additional 470,522 shares during the period. Finally, Janus Henderson Group PLC bought a new position in AngioDynamics in the 2nd quarter valued at about $15,619,000. Institutional investors and hedge funds own 95.29% of the company’s stock.

ANGO has been the topic of several recent analyst reports. Zacks Investment Research raised shares of AngioDynamics from a “hold” rating to a “buy” rating and set a $19.00 target price on the stock in a report on Tuesday, October 3rd. Canaccord Genuity reissued a “hold” rating and issued a $17.00 target price on shares of AngioDynamics in a report on Sunday, October 8th. KeyCorp reissued a “hold” rating on shares of AngioDynamics in a report on Friday, September 29th. Finally, BidaskClub raised shares of AngioDynamics from a “sell” rating to a “hold” rating in a report on Saturday, August 19th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $18.60.

Shares of AngioDynamics, Inc. (ANGO) opened at $17.03 on Monday. The stock has a market cap of $625.27, a P/E ratio of 24.68, a P/E/G ratio of 1.75 and a beta of 1.04. The company has a current ratio of 2.34, a quick ratio of 1.48 and a debt-to-equity ratio of 0.17. AngioDynamics, Inc. has a 1-year low of $14.80 and a 1-year high of $18.85.

AngioDynamics (NASDAQ:ANGO) last announced its quarterly earnings results on Thursday, September 28th. The medical instruments supplier reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.16 by ($0.04). The company had revenue of $85.40 million for the quarter, compared to the consensus estimate of $86.12 million. AngioDynamics had a net margin of 1.64% and a return on equity of 4.83%. The company’s revenue for the quarter was down 3.1% compared to the same quarter last year. During the same period last year, the firm posted $0.17 earnings per share. research analysts anticipate that AngioDynamics, Inc. will post 0.65 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This article was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another site, it was stolen and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/12/11/trexquant-investment-lp-invests-175000-in-angiodynamics-inc-ango-stock.html.

AngioDynamics Profile

AngioDynamics, Inc designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company’s devices are used in minimally invasive, image-guided procedures.

Want to see what other hedge funds are holding ANGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AngioDynamics, Inc. (NASDAQ:ANGO).

Institutional Ownership by Quarter for AngioDynamics (NASDAQ:ANGO)

Receive News & Stock Ratings for AngioDynamics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics Inc. and related stocks with our FREE daily email newsletter.